Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
73.6 CHF | 0.00% | +4.10% | +44.79% |
04-26 | Cosmo Pharmaceuticals N.V. Announces Executive Changes at the Upcoming Annual General Meeting on 24 May 2024 | CI |
04-25 | Cosmo Pharmaceuticals Names New CEO, Chairman | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+44.79% | 1.31B | |
+33.33% | 709B | |
+30.78% | 595B | |
-2.26% | 367B | |
+20.32% | 334B | |
+4.81% | 289B | |
+14.23% | 239B | |
+9.23% | 211B | |
-3.31% | 203B | |
+8.46% | 171B |
- Stock Market
- Equities
- COPN Stock
- News Cosmo Pharmaceuticals N.V.
- Cosmo Pharmaceuticals Wins Japanese Nod For Ulcerative Colitis Drug